Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 55401-55450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06256380
Comparing Enhanced Cognitive-behavior Therapy and Family-based Treatment for Adolescents With an Eating Disorder
NARecruiting
200 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2033
1 condition9 sponsors5 locations
NCT06314906
Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
PHASE3Recruiting
370 participants
Started: Mar 7, 2024 · Completed: Mar 31, 2027
3 conditions1 sponsor1 location
NCT06438185
Efficacy And Safety of An IRE System For Treatment of Inferior Turbinate Hypertrophy
NARecruiting
40 participants
Started: Mar 7, 2024 · Completed: Mar 31, 2026
3 conditions1 sponsor4 locations
NCT06242119
Clinical Application of the J-PET Scanner Prototype
N/ARecruiting
25 participants
Started: Mar 7, 2024 · Completed: Oct 30, 2025
6 conditions2 sponsors1 location
NCT06074133
A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules
N/ARecruiting
100 participants
Started: Mar 7, 2024 · Completed: Mar 31, 2029
1 condition2 sponsors4 locations
NCT06090734
Development and Evaluation of 'My Voice': a Randomized Controlled Trial
NARecruiting
244 participants
Started: Mar 7, 2024 · Completed: Feb 28, 2026
2 conditions6 sponsors1 location
NCT06346613
Prevalence and Affecting Factors of Sleep and Circadian Rhythm Disorders in ICU
N/ARecruiting
56 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06562270
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
N/ARecruiting
1,500 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2099
1 condition1 sponsor1 location
NCT06314373
A Study for HSK39775 in Participants With Solid Tumors
PHASE1/PHASE2Recruiting
243 participants
Started: Mar 7, 2024 · Completed: Sep 1, 2028
1 condition1 sponsor1 location
NCT06507449
The Influence of Modifying Highly Calcified Coronary Lesions on Coronary Microcirculation
NAEnrolling by invitation
30 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2026
6 conditions2 sponsors1 location
NCT06298864
Internet-based Behavioral Intervention Following ACS
NARecruiting
176 participants
Started: Mar 7, 2024 · Completed: Oct 31, 2027
2 conditions2 sponsors1 location
NCT06194929
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
PHASE1/PHASE2Recruiting
33 participants
Started: Mar 7, 2024 · Completed: Jan 15, 2030
1 condition2 sponsors2 locations
NCT04017819
Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05913713
HIIT Following Breast Cancer Chemotherapy
NARecruiting
158 participants
Started: Mar 7, 2024 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT06636812
Losartan and Emotional Processing in Young People
EARLY_PHASE1Recruiting
60 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06191978
A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
PHASE1Recruiting
40 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT05987644
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
PHASE1/PHASE2Recruiting
56 participants
Started: Mar 7, 2024 · Completed: Jan 31, 2027
3 conditions2 sponsors3 locations
NCT06088381
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
PHASE2Recruiting
61 participants
Started: Mar 7, 2024 · Completed: Oct 18, 2027
5 conditions1 sponsor5 locations
NCT06310811
Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
NARecruiting
12 participants
Started: Mar 7, 2024 · Completed: Mar 1, 2027
2 conditions1 sponsor1 location
NCT06252818
Validation of a Digital Platform for Functional Respiratory Rehabilitation
NARecruiting
100 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT06214572
Radiation Therapy in Unresectable Gall Bladder Cancer
PHASE2/PHASE3Recruiting
249 participants
Started: Mar 7, 2024 · Completed: Jul 21, 2029
1 condition1 sponsor1 location
NCT06827444
The Role of Attention in Modulating the Placebo Effect
NARecruiting
128 participants
Started: Mar 7, 2024 · Completed: May 31, 2025
2 conditions1 sponsor1 location
NCT06344481
The Hyalex First-in-Human Study
NARecruiting
15 participants
Started: Mar 7, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor2 locations
NCT07042633
Mechanism of Gamma Oscillation Synchronization in the Prefrontal-hippocampal Circuit for Memory Dysfunction in Patients With White Matter Lesions of Cerebral Small Vessel Disease
N/ARecruiting
150 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT05646381
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
PHASE2Recruiting
502 participants
Started: Mar 7, 2024 · Completed: Mar 12, 2030
1 condition1 sponsor124 locations
NCT05931406
Effects of a Sedentary Behaviors at Work on Health in Emergency Medical Dispatchers and CODIS Operators (SECODIS)
NARecruiting
36 participants
Started: Mar 7, 2024 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT06327997
An Exploratory Study by Fast CAR T Cells
EARLY_PHASE1Recruiting
20 participants
Started: Mar 7, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06217822
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
PHASE1Recruiting
235 participants
Started: Mar 7, 2024 · Completed: May 24, 2031
2 conditions1 sponsor33 locations
NCT06216938
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
EARLY_PHASE1Recruiting
25 participants
Started: Mar 7, 2024 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT06266793
Comparison of Holmium Laser and Thulium Laser for Mini PCNL
NAEnrolling by invitation
52 participants
Started: Mar 7, 2024 · Completed: Jun 1, 2027
2 conditions2 sponsors1 location
NCT06111976
Repetitive Transcranial Magnetic Stimulation Plus Reactivation Therapy Efficacy on PTSD Symptom Severity in Resistant PTSD
NARecruiting
102 participants
Started: Mar 7, 2024 · Completed: Oct 7, 2026
1 condition1 sponsor1 location
NCT06511453
Acupressure in Patients With Sickle Cell Disease
NARecruiting
240 participants
Started: Mar 7, 2024 · Completed: Aug 31, 2029
1 condition2 sponsors2 locations
NCT06262867
Early Allergen System Experience
NAActive, not recruiting
1,110 participants
Started: Mar 7, 2024 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT06566976
Prehabilitation and Rehabilitation in PAD
NARecruiting
300 participants
Started: Mar 7, 2024 · Completed: Jul 25, 2027
1 condition2 sponsors1 location
NCT06168760
Hand Dexterity and Anthropometric Measurement
N/ANot yet recruiting
161 participants
Started: Mar 7, 2024 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT05933434
Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy
PHASE1/PHASE2Recruiting
80 participants
Started: Mar 7, 2024 · Completed: Oct 31, 2030
1 condition1 sponsor1 location
NCT06306482
Determination of Posture in Patients With Restrictive and Obstructive Lung Disease
N/ANot yet recruiting
90 participants
Started: Mar 7, 2024 · Completed: Mar 7, 2026
3 conditions1 sponsor2 locations
NCT06386471
Personalized GI Motility Responses to Diet
NARecruiting
50 participants
Started: Mar 7, 2024 · Completed: Jun 2, 2025
4 conditions1 sponsor1 location
NCT06270966
Cognitive Remediation VR Tool for People With MCI: a Feasibility RCT
NANot yet recruiting
30 participants
Started: Mar 7, 2024 · Completed: Dec 1, 2025
4 conditions1 sponsor1 location
NCT06047626
Living Well With Lymphoma
NARecruiting
68 participants
Started: Mar 7, 2024 · Completed: Sep 30, 2028
1 condition2 sponsors1 location
NCT06312527
Mepiform in Simultaneous Bilateral TKA
NAActive, not recruiting
30 participants
Started: Mar 7, 2024 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT06668818
Clinical Nursing Practice Supported by Results of Research: Mixed-method Study
N/ARecruiting
205 participants
Started: Mar 7, 2024 · Completed: Mar 7, 2025
1 condition1 sponsor1 location
NCT06044857
PSMA PET Response Guided SabR in High Risk Pca
PHASE1Recruiting
20 participants
Started: Mar 7, 2024 · Completed: Nov 30, 2026
1 condition3 sponsors2 locations
NCT06351865
Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital Consent
N/ARecruiting
50 participants
Started: Mar 7, 2024 · Completed: Oct 31, 2025
2 conditions2 sponsors1 location
NCT06381726
Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life
NARecruiting
400 participants
Started: Mar 7, 2024 · Completed: Feb 28, 2028
2 conditions2 sponsors1 location
NCT06131398
A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
PHASE1Recruiting
535 participants
Started: Mar 7, 2024 · Completed: Mar 25, 2028
1 condition1 sponsor25 locations
NCT06118788
Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
PHASE1/PHASE2Recruiting
24 participants
Started: Mar 7, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor3 locations
NCT06706973
Profiling and Targeting Epigenetic Marks to Improve Diagnosis and Therapeutic Approaches in Head and Neck Cancer
N/ARecruiting
60 participants
Started: Mar 6, 2024 · Completed: Apr 4, 2030
1 condition2 sponsors1 location
NCT05513027
Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection
NAActive, not recruiting
11 participants
Started: Mar 6, 2024 · Completed: May 31, 2027
1 condition2 sponsors1 location
NCT06237426
An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD
PHASE2Enrolling by invitation
150 participants
Started: Mar 6, 2024 · Completed: May 31, 2027
1 condition1 sponsor9 locations